Table 4 Adherence to guidelines across 84 primary car practices*
Process of care manoeuvre | Percentage of patients receiving care [95% CI] |
|---|---|
All (n = 4931) | Â |
 2 Blood pressure measures | 74.8% [71.3-78.3%] |
 Lipid profile | 77.7% [74.9-80.4%] |
 Waist circumference measure | 9.9% [6.7-13.0%] |
 Dietician/weight loss program referral | 18.2% [14.3-22.2%] |
 Smoking status recorded | 95.4% [93.9-97.0%] |
Coronary Artery Disease (n = 1510) | Â |
 Fasting blood glucose | 80.0% [77.2-82.8%] |
 Medication (ACE, Angiotensin receptor blocker, beta blocker) | 88.5% [86.5-90.4%] |
 ASA | 76.0% [73.2-78.9%] |
Peripheral Vascular Disease (n = 318) | Â |
 Fasting blood glucose | 78.9% [74.6-83.2%] |
 ACE inhibitor and/or Angiotensin receptor blocker | 66.9% [61.4-72.5%] |
 Lipid lowering medication | 83.3% [77.8-88.8%] |
 ASA | 75.8% [70.3-81.2%] |
Stroke (n = 636) | Â |
 Fasting blood glucose | 76.9% [72.8-81.0%] |
 ASA | 78.9% [74.7-83.2%] |
If stroke within past year (n = 71) | Â |
 Echo cardiogram | 47.9% [38.6-65.6%] |
 Carotid doppler | 59.6% [43.7-74.7%] |
 CT head scan | 66.2% [52.6-79.8%] |
 EKG | 52.1% [38.6-65.6%] |
Diabetes (n = 2308) | Â |
 Two hemoglobin A1c tests | 54.9% [50.1-59.6%] |
 Glycemic control medication | 80.5% [78.0-83.0%] |
 ACR | 55.8% [50.6-61.0%] |
 eGFR | 83.8% [80.8-86.8%] |
Chronic Kidney Disease (n = 916) | Â |
 ACR | 51.6% [46.3-57.0%] |
Dyslipidemia (n = 4111) | Â |
 Lipid profile | 82.8% [80.9-84.7%] |
 Lipid lowering medication | 91.5% [90.1-92.8%] |
Hypertension (n = 3793) | Â |
 Two blood pressure readings | 79.4% [76.0-82.8%] |
 Anti-Hypertensive medication | 94.2% [93.1-95.3%] |
Smoking (n = 1049) | Â |
 Smoking cessation counselling | 52.8% [46.9-58.8%] |
 Smoking cessation program | 7.7% [5.1-10.6%] |
 Smoking cessation drug | 23.1% [19.2-27.1%] |